Compare UFCS & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UFCS | INMD |
|---|---|---|
| Founded | 1946 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 927.2M | 879.2M |
| IPO Year | N/A | 2019 |
| Metric | UFCS | INMD |
|---|---|---|
| Price | $36.93 | $14.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 6 |
| Target Price | ★ $33.00 | $17.00 |
| AVG Volume (30 Days) | 117.5K | ★ 581.0K |
| Earning Date | 11-04-2025 | 02-03-2026 |
| Dividend Yield | ★ 1.74% | N/A |
| EPS Growth | ★ 118.04 | 20.42 |
| EPS | ★ 4.24 | 2.21 |
| Revenue | ★ $1,353,781,000.00 | $364,494,000.00 |
| Revenue This Year | $10.11 | N/A |
| Revenue Next Year | $3.33 | $3.76 |
| P/E Ratio | $8.68 | ★ $6.56 |
| Revenue Growth | ★ 12.12 | N/A |
| 52 Week Low | $24.11 | $13.14 |
| 52 Week High | $37.84 | $19.78 |
| Indicator | UFCS | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 61.73 | 48.58 |
| Support Level | $33.53 | $14.24 |
| Resistance Level | $36.87 | $14.58 |
| Average True Range (ATR) | 0.97 | 0.26 |
| MACD | -0.13 | 0.06 |
| Stochastic Oscillator | 77.73 | 62.64 |
United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.